Skip to main content

Table 1 RNA based therapeutics in clinical trials in lung cancer

From: RNA-based therapies: A cog in the wheel of lung cancer defense

Drug combination Affected Pathway References
Custirsen + gemcitabine + cisplatin Clusterin [288]
Aprinocarsen + gemcitabine + cisplatin PKC-a [300, 303, 304]
Imetelstat + bevacizumab Telomerase [286]
LY2181308 + docetaxel Survivin [305]
Oblimersen + paclitaxel Bcl2 [283]
Oblimersen + carboplatin + etoposide Bcl2 [285]